Replacement of HLA class II serology by the HLA‐DR microtitre plate oligotyping assay: a one‐year experience in unrelated bone marrow donor selection
- 1 October 1993
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 85 (2) , 417-418
- https://doi.org/10.1111/j.1365-2141.1993.tb03191.x
Abstract
Because the selection of unrelated bone marrow donors requires a more accurate HLA-typing technique than is used for sibling donors, we have replaced class II serology by a rapid and highly discriminative HLA-DR DNA oligotyping assay on microtitre plates. We present here our 1-year experience with class II typing for 112 potential donors identified for 33 consecutive leukaemic patients. Although the donors were selected to be HLA-A, -B, -DR serologically identical, the microtitre plate oligotyping assay detected DR incompatibilities in 52.7% of the patient/donor pairs. One third was due to incorrect or incomplete typing of DR11 to DR16, the others to mismatches for the serologically indistinguishable subtypes of DR1, 11, 13 and 15, known to be relevant for T cell recognition.Keywords
This publication has 10 references indexed in Scilit:
- THE FREQUENCY OF PRETRANSPLANT DONOR CYTOTOXIC T CELL PRECURSORS WITH ANTI-HOST SPECIFICITY PREDICTS SURVIVAL OF PATIENTS TRANSPLANTED WITH BONE MARROW FROM DONORS OTHER THAN HLA-IDENTICAL SIBLINGSTransplantation, 1993
- Analysis of 462 Transplantations from Unrelated Donors Facilitated by the National Marrow Donor ProgramNew England Journal of Medicine, 1993
- Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor ProgramBlood, 1993
- Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locusBlood, 1993
- Oligonucleotide geriotyping of HLA polymorphism on microtitre platesThe Lancet, 1992
- Nomenclature for factors of the HLA system, 1991Tissue Antigens, 1992
- Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization.Proceedings of the National Academy of Sciences, 1991
- MARROW TRANSPLANTATION FROM HLA-MATCHED UNRELATED DONORS FOR TREATMENT OF HEMATOLOGIC MALIGNANCIESTransplantation, 1991
- Successful Allogeneic Transplantation of T-Cell–Depleted Bone Marrow from Closely HLA-Matched Unrelated DonorsNew England Journal of Medicine, 1990
- Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemiaBlood, 1986